Walmsley, who helped push GSK to focus more exclusively on specialty medicines and oncology, will be succeeded by commercial ...

GSK's CEO Emma Walmsley will step down at the end of the year and be replaced by insider Luke Miels, the drugmaker said on ...

GSK announced that Luke Miels, the company’s chief commercial officer, will take over as CEO on Jan. 1, replacing Emma ...

Commercial chief Luke Miels will take the helm as the pharma company seeks to bring to replenish its product lineup to offset ...

The move caps Walmsley's over eight years in the role that made her the most senior female CEO in the UK. She drove the ...

Nearly nine years ago, when Emma Walmsley was preparing to take over as CEO of GSK Plc, she wrote in her diary that Luke ...

GSK plc names new CEO as shares rise 3% and maintains a 4% dividend yield; get key insights on GSK stock's outlook and what ...

Emma Walmsley’s departure comes as GSK works to strengthen its drug pipeline and offset the upcoming loss of patent ...

Emma Walmsley has overseen eight turbulent years at he U.K. drugmaker. The firm announced Monday that she will be succeeded ...

In many countries, tattoos are seen as fashion statements and personal expression, especially among the youth. While reflecting ...

A long-acting HIV jab promises near-perfect protection at just $40 a year, but 115 nations must wait for India's approval of ...

In an exclusive interview with The Blast, Lukas Gage speaks about the importance of prioritizing health and well-being.